Frontlight ResearchEarly access
Trial site
Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center (Site 1028)
- 1running trial
- 1closed trial
The trials here
What the 2 trials at this site are about, from their registry records.
- Conditions
- High blood pressure2 trials
- Pulmonary arterial hypertension2 trials
- Heart failure1 trial
- Phase
- Phase 21 trial
- Phase 31 trial
- Status
- Active, not recruiting1 trial
- Completed1 trial
- Lead sponsor
- Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA1 trial
- Merck Sharp & Dohme LLC1 trial
Running trials
Closed trials
Site data: ClinicalTrials.govUpdated 13 Nov 2026